I agree that this site is using cookies. You can find further informations here.
X
Abboud, Camille
193  results:
Search for persons X
?
1

Dose-Response Demonstrated for Durable Complete Remission F..:

Chen, George L ; Abboud, Camille ; Gyurkocza, Boglarka...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S114-S115 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Targeted Myeloablative Radiation Using 131I-Apamistamab Pri..:

Choe, Hannah ; Nath, Dr. Rajneesh ; Seropian, Dr. Stuart E....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S59-S60 , 2024
Link: https://doi.org/10.1016/..
 
?
3

131I-Apamistamab Improves Outcomes in Patients 65 Years and..:

Nath, Rajneesh ; Seropian, Stuart ; Gyurkocza, Boglarka...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S54-S55 , 2024
Link: https://doi.org/10.1016/..
 
?
4

131I-Apamistamab-Led Allogeneic Hematopoietic Cell Transpla..:

Foran, James ; Gyurkocza, Boglarka ; Nath, Rajneesh...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S110-S111 , 2024
Link: https://doi.org/10.1016/..
 
?
5

POSTER: AML-521 The Randomized Phase III SIERRA (Study of I..:

Nath, Rajneesh ; Seropian, Stuart ; Choe, Hannah...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S167 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Phase I-II Trial of Early Azacitidine after Matched Unrelat..:

Xu, Ziheng ; Choi, Jaebok ; Cooper, Matthew...
Transplantation and Cellular Therapy.  29 (2023)  11 - p. 699.e1-699.e9 , 2023
Link: https://doi.org/10.1016/..
 
?
7

S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IO..:

Gyurkocza, Boglarka ; Seropian, Stuart ; Choe, Hannah...
HemaSphere.  7 (2023)  S3 - p. e2941723 , 2023
Link: https://doi.org/10.1097/..
 
?
8

P526: SAFETY AND EFFICACY UPDATE FROM CLI120-001: A PHASE1B..:

Lech-Marańda, Ewa ; Szymańska, Agata ; Zaucha, Jan...
HemaSphere.  7 (2023)  S3 - p. e27994b8 , 2023
Link: https://doi.org/10.1097/..
 
?
9

AML-521 The Randomized Phase III SIERRA (Study of Iomab-B i..:

Nath, Rajneesh ; Seropian, Stuart ; Choe, Hannah...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S309-S310 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Characteristics of Graft-Versus-Host Disease (GvHD) After P..:

Saliba, Rima M. ; Alousi, Amin M. ; Pidala, Joseph...
Transplantation and Cellular Therapy.  28 (2022)  10 - p. 681-693 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Use of Belimumab for Prophylaxis of Chronic Graft-Versus-Ho..:

Pusic, Iskra ; Johanns, Tanner ; Sarantopoulos, Stefanie...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S31 , 2022
Link: https://doi.org/10.1016/..
 
?
12

High Rates of Transplantation in the Phase III Sierra Trial..:

Gyurkocza, Boglarka ; Nath, Rajneesh ; Seropian, Stuart E....
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S35-S36 , 2022
Link: https://doi.org/10.1016/..
 
?
13

A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective..:

Abboud, Ramzi ; Gao, Feng ; Rettig, Michael P....
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S298-S299 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Letermovir Discontinuation at Day 100 After Allogeneic Stem..:

Liu, Lawrence Wayne ; Yn, Alicia ; Gao, Feng...
Transplantation and Cellular Therapy.  28 (2022)  8 - p. 510.e1-510.e9 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Myeloablative Targeted Conditioning with Anti-CD45 Iodine (..:

Nath, Rajneesh ; Gyurkocza, Boglarka ; Choe, Hannah...
Transplantation and Cellular Therapy.  27 (2021)  3 - p. S56 , 2021
Link: https://doi.org/10.1016/..
 
1-15